help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bird, I. M.
Right arrow Articles by Rainey, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bird, I. M.
Right arrow Articles by Rainey, W. E.

Endocrinology, Vol 130, 3113-3121, Copyright © 1992 by Endocrine Society


ARTICLES

Angiotensin-II acts via the type 1 receptor to inhibit 17 alpha- hydroxylase cytochrome P450 expression in ovine adrenocortical cells

IM Bird, RR Magness, JI Mason and WE Rainey
Cecil H. and Ida Green Center for Reproductive Biology Sciences, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

In this study we have investigated the effect of angiotensin-II (A-II) on cortisol production and 17 alpha-hydroxylase cytochrome P450 (P450(17 alpha)) expression in primary cultures of ovine adrenocortical cells and the A-II receptor subtypes that mediate these responses. While A-II alone had no stimulatory effect on cortisol secretion, it inhibited the cortisol response to ACTH (10(-8) M) in a dose-dependent manner (Ki, less than 0.1 nM; maximum inhibition, 60-80%). While prolonged treatment with ACTH (10(-8) M) increased the expression of P450(17 alpha), cotreatment with A-II (10(-8) M) also inhibited ACTH- stimulated expression, as determined by changes in mRNA, immunoreactive P450(17 alpha), and 17 alpha-hydroxylase activity. A study of the effects of the AT1 and AT2 receptor antagonists, DuP 753 and PD 123319, on binding of [125I]A-II to ovine adrenocortical cells showed that the A-II receptor population was predominantly of the AT1 subtype. The effects of A-II on inhibition of cortisol secretion in response to ACTH and the activation of phosphoinositidase-C in response to A-II alone were both fully antagonized by DuP 753, but not by PD 123319. Furthermore, the inhibitory effects of A-II on expression of P450(17 alpha), as measured at the levels of mRNA, immunoreactive protein, and enzyme activity, were reversed by DuP 753 (10(-5) M), but not PD 123319 (10(-5) M). We conclude that A-II has a potentially important role in the control of cortisol secretion and long term maintenance of P450(17 alpha) expression in the ovine adrenal cortex, and that the effects of A-II on both cortisol secretion and P450(17 alpha) expression are mediated through the AT1 receptor, which is coupled to phosphoinositidase-C.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome
Endocr. Rev., February 1, 2001; 22(1): 75 - 110.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez
Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase
Endocrinology, May 1, 2000; 141(5): 1599 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. L. Coulter, D. A. Myers, P. W. Nathanielsz, and I. M. Bird
Ontogeny of Angiotensin II Type 1 Receptor and Cytochrome P450c11 in the Sheep Adrenal Gland
Biol Reprod, March 1, 2000; 62(3): 714 - 719.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. R. Poore, I. R. Young, B. J. Canny, and G. D. Thorburn
Angiotensin II infusion in vivo does not modulate cortisol secretion in the late-gestation ovine fetus
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R357 - R362.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. M. Bird, J. I. Mason, and W. E. Rainey
Protein Kinase A, Protein Kinase C, and Ca2+-Regulated Expression of 21-Hydroxylase Cytochrome P450 in H295R Human Adrenocortical Cells
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1592 - 1597.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson
Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis
Endocr. Rev., April 1, 1998; 19(2): 101 - 143.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. H. Wang, J. Qiu, Z. Hu, and Y. Du
Regulation of Type 1 Angiotensin II Receptor in Adrenal Gland : Role of {alpha}1-Adrenoreceptor
Hypertension, September 1, 1997; 30(3): 345 - 350.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
I. M. Bird, J. Zheng, J. M. Cale, and R. R. Magness
Pregnancy Induces an Increase in Angiotensin II Type-1 Receptor Expression in Uterine But Not Systemic Artery Endothelium
Endocrinology, January 1, 1997; 138(1): 490 - 498.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. M. Bird, R. A. Word, C. Clyne, J. I. Mason, and W. E. Rainey
Potassium Negatively Regulates Angiotensin II Type 1 Receptor Expression in Human Adrenocortical H295R Cells
Hypertension, June 1, 1995; 25(6): 1129 - 1134.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society